Jensen P S
National Institute of Mental Health, Rockville, Maryland 20857, USA.
Can J Psychiatry. 1998 Aug;43(6):585-8. doi: 10.1177/070674379804300606.
To provide an overview of the knowledge base concerning the prescribing of psychotropic agents in young children with mental disorder and related mental health problems.
Relevant information is reviewed concerning the knowledge base available to inform pediatric psychopharmacology prescribing practices.
Very few psychoactive medications have been adequately tested for safety and efficacy in young children, despite relatively high rates of prescribing.
Behavioral and psychotherapeutic strategies are often the wisest first therapeutic intervention for this age group. Psychotropic medications may be required, but should be used cautiously in young children, while additional studies are being conducted.
概述有关患有精神障碍及相关心理健康问题的幼儿使用精神药物的知识库。
回顾了有关可为儿科精神药理学处方实践提供参考的知识库的相关信息。
尽管开药率相对较高,但很少有精神活性药物在幼儿中进行过充分的安全性和有效性测试。
行为和心理治疗策略通常是该年龄组最明智的首要治疗干预措施。可能需要使用精神药物,但在进行更多研究的同时,应谨慎用于幼儿。